These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 18034997)
1. Microalbuminuria in Thai essential hypertensive patients. Buranakitjaroen P; Phoojaroenchanachai M; Saravich S J Int Med Res; 2007; 35(6):836-47. PubMed ID: 18034997 [TBL] [Abstract][Full Text] [Related]
2. Microalbuminuria in essential hypertension. Mimran A Clin Exp Hypertens; 1997; 19(5-6):753-67. PubMed ID: 9247753 [TBL] [Abstract][Full Text] [Related]
3. Prevalence and risk factors of microalbuminuria in Thai nondiabetic hypertensive patients. Gojaseni P; Phaopha A; Chailimpamontree W; Pajareya T; Chittinandana A Vasc Health Risk Manag; 2010 Mar; 6():157-65. PubMed ID: 20448800 [TBL] [Abstract][Full Text] [Related]
4. Reverse white-coat effect as an independent risk for microalbuminuria in treated hypertensive patients. Kato T; Horio T; Tomiyama M; Kamide K; Nakamura S; Yoshihara F; Nakata H; Nakahama H; Kawano Y Nephrol Dial Transplant; 2007 Mar; 22(3):911-6. PubMed ID: 17142262 [TBL] [Abstract][Full Text] [Related]
5. Hypertension audit in clinical practice based in Thailand (HABIT). Buranakitjaroen P J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S57-65. PubMed ID: 21721429 [TBL] [Abstract][Full Text] [Related]
6. MicroAlbuminuria Prevalence Study (MAPS) in hypertensive type 2 diabetic patients in Hong Kong. Yeung VT; Lee KF; Chan SH; Ho LF; Leung SK; Wong HY; Hong Kong Med J; 2006 Jun; 12(3):185-90. PubMed ID: 16760545 [TBL] [Abstract][Full Text] [Related]
9. Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial. Ruggenenti P; Perna A; Ganeva M; Ene-Iordache B; Remuzzi G; J Am Soc Nephrol; 2006 Dec; 17(12):3472-81. PubMed ID: 17082240 [TBL] [Abstract][Full Text] [Related]
10. Microalbuminuria and hypertension in HIV-infected patients: a preliminary study of telmisartan. Ucciferri C; Falasca K; Mancino P; Di Iorio A; Vecchiet J Eur Rev Med Pharmacol Sci; 2012 Apr; 16(4):491-8. PubMed ID: 22696876 [TBL] [Abstract][Full Text] [Related]
11. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment]. Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399 [TBL] [Abstract][Full Text] [Related]
12. Administration of an angiotensin-converting enzyme inhibitor improves vascular function and urinary albumin excretion in low-risk essential hypertensive patients receiving anti-hypertensive treatment with calcium channel blockers. Organ-protecting effects independent of anti-hypertensive effect. Watanabe Y; Takasugi E; Shitakura K; Okajima K; Hota N; Kubo Y; Nunoda S; Otsuka K Clin Exp Hypertens; 2011; 33(4):246-54. PubMed ID: 21699451 [TBL] [Abstract][Full Text] [Related]
13. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs. Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973 [TBL] [Abstract][Full Text] [Related]
14. Influence of microalbuminuria in achieving blood pressure goals. Duka I; Bakris G Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):457-63. PubMed ID: 18695385 [TBL] [Abstract][Full Text] [Related]
15. Microalbuminuria in essential hypertension. Mimran A; Ribstein J; Du Cailar G Curr Opin Nephrol Hypertens; 1999 May; 8(3):359-63. PubMed ID: 10456269 [TBL] [Abstract][Full Text] [Related]
16. Prevalence and factors associated with microalbuminuria and abnormal renal function in Thai obese adults. Eiamthanasinchai S; Laowahutanont N; Yamwong P; Teerapornlertratt T J Med Assoc Thai; 2013 Feb; 96 Suppl 2():S9-16. PubMed ID: 23590016 [TBL] [Abstract][Full Text] [Related]
17. Office and ambulatory pulse pressure--association with clinical characteristics and cardiovascular risk factors in normoalbuminuric patients with type 2 diabetes (ROADMAP study). Januszewicz A; Ritz E; Viberti G; Mimran A; Rabelink AJ; Rump LC; Ruilope LM; Katayama S; Ito S; Izzo JL; Haller H J Hum Hypertens; 2011 Nov; 25(11):679-85. PubMed ID: 21150933 [TBL] [Abstract][Full Text] [Related]
18. Quinapril reduces microalbuminuria in essential hypertensive and in diabetic hypertensive subjects. Dominguez LJ; Barbagallo M; Kattah W; Garcia D; Sowers JR Am J Hypertens; 1995 Aug; 8(8):808-14. PubMed ID: 7576397 [TBL] [Abstract][Full Text] [Related]
19. Blood pressure control is similar in treated hypertensive patients with optimal or with high-normal albuminuria. Oliveras A; Armario P; Lucas S; de la Sierra A; Am J Hypertens; 2014 Sep; 27(9):1185-90. PubMed ID: 24646879 [TBL] [Abstract][Full Text] [Related]